About Chengdu Easton Biopharmaceuticals Company

The company is a high-tech enterprise driven by R&D and innovation, integrating R&D, production and sales of chemical raw materials, high-end chemicals and biopharmaceuticals. The company was founded in 2009, has 8 wholly-owned subsidiaries, and currently employs more than 1,400 people. The company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange in September 2020. The company is a high-tech enterprise, driven by R&D and innovation, integrating the entire R&D, production and sales industry chain of chemical raw materials, high-end chemicals and biopharmaceuticals. The company's main products include high-end chemicals, small molecule innovative drugs, biopharmaceuticals, and APIs. Company honors: Sichuan Province Intellectual Property Strong Enterprise Cultivating Enterprise, 2022 Sichuan Health Industry Outstanding Enterprise, 2022 Sichuan Enterprise Top 20 Enterprise with the Most Potential for Technological Innovation and Development, 2022 Top 100 Sichuan Enterprises with Invention Patents, 2022 Best Industrial Enterprise in China Pharmaceutical R&D Product Line, 2022 Honorary Title of “Quality Craftsman Enterprise” in the Chinese Pharmaceutical Industry, “National Technological Innovation Demonstration Enterprise” and “National Green Factory”, “2022 China's Top 100 Pharmaceutical Innovation Enterprises”, etc.